Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

Brian Godman*, Rickard E. Malmström, Eduardo Diogene, Sisira Jayathissa, Stuart McTaggart, Thomas Cars, Samantha Alvarez-Madrazo, Christoph Baumgärtel, Anna Brzezinska, Anna Bucsics, Stephen Campbell, Irene Eriksson, Alexander Finlayson, Jurij Fürst, Kristina Garuoliene, Iñaki Gutiérrez-Ibarluzea, Krystyna Hviding, Harald Herholz, Roberta Joppi, Marija KalabaOtt Laius, Kamila Malinowska, Hanne B. Pedersen, Vanda Markovic-Pekovic, Jutta Piessnegger, Gisbert Selke, Catherine Sermet, Susan Spillane, Dominik Tomek, Luka Vončina, Vera Vlahović-Palčevski, Janet Wale, Magdalena Wladysiuk, Menno van Woerkom, Corinne Zara, Lars L. Gustafsson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences